PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
23-Feb-2023 Genmab Publishes 2022 Annual Report Genmab
23-Feb-2023 EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific EVERSANA CONSULTING
23-Feb-2023 iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer iOmx Therapeutics AG
23-Feb-2023 : Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023 Biophytis
23-Feb-2023 Gerresheimer AG: Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels Gerresheimer AG
22-Feb-2023 Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration Essex Bio-Technology Limited
22-Feb-2023 Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors ABIVAX
22-Feb-2023 MODERNA AND LIFE EDIT THERAPEUTICS ENTER STRATEGIC COLLABORATION TO ACCELERATE THE DEVELOPMENT OF NOVEL IN VIVO GENE EDITING THERAPIES MODERNA
22-Feb-2023 PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA PHARMANOVIA
22-Feb-2023 NICE Publishes Reimbursement Recommendation for Translarna™ PTC Therapeutics, Ltd.
22-Feb-2023 Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP) Ferrer
22-Feb-2023 ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV in Europe ViiV Healthcare
22-Feb-2023 Mettler-Toledo to Host a Live Webinar on Glass in Glass X-ray Inspection Mettler-Toledo
22-Feb-2023 eXmoor pharma and vaccine developer Imophoron sign process development partnership eXmoor pharma
22-Feb-2023 Prof. Molly Stevens receives the Novo Nordisk Prize – Understanding how materials and biology interact has revolutionised healthcare technologies Novo Nordisk Foundation
22-Feb-2023 Brainomix Technology Integrated into New UK Atrial Fibrillation Study Brainomix
22-Feb-2023 BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment BRAIN Biotech AG
22-Feb-2023 Medios AG: Record revenue and earnings – Guidance 2022 achieved; further growth expected in financial year 2023 Medios AG
21-Feb-2023 Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation Fresenius Medical Care AG & Co. KGaA
21-Feb-2023 Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft) Fresenius SE & Co. KGaA